Amneal Pharmaceuticals of New York, LLC recalls

25 recalls on record · latest: March 25, 2024

Official U.S. recall history for Amneal Pharmaceuticals of New York, LLC, compiled from official government records.

Get recall alerts

Free email alert whenever Amneal Pharmaceuticals of New York, LLC has a new recall — straight from official government data. Unsubscribe anytime.

Amneal Pharmaceuticals of New York, LLC recalls Methylergonovine Maleate Tablets, USP, 0.2mg, 12-count bottle, Rx Only, Distributed by: Amneal Pharmaceuticals, LLC, Br…

March 25, 2024 · Drug & medication recalls Moderate risk Failed Dissolution Specifications

Amneal Pharmaceuticals of New York, LLC recalls Vancomycin Hydrochloride for Oral Solution, USP, 250 mg per 5 mL, packaged as (a) 80 mL bottle, NDC 69238-2261-3; (b) 1…

March 21, 2024 · Drug & medication recalls High risk Superpotent Drug: Due to overfilling of drug powder

Amneal Pharmaceuticals of New York, LLC recalls Oseltamivir Phosphate for Oral Suspension 6mg/ml, 60 mL (reconstituted) bottle, RX only, Distributed by Amneal Pharmace…

February 13, 2024 · Drug & medication recalls Moderate risk Failed Impurities/Degradation Specifications: Out-of-specification test results.

Amneal Pharmaceuticals of New York, LLC recalls Phenoxybenzamine Hydrochloride Capsules, USP 10mg, 100-count bottle, Rx only, Manufactured by: Amneal Pharmaceuticals P…

January 15, 2024 · Drug & medication recalls Moderate risk Failed Impurities/Degradation Specifications: Out of specification for unknown…

Amneal Pharmaceuticals of New York, LLC recalls Divalproex Sodium Extended-release Tablets, USP 250 mg, Rx Only, 100 tablets, Manufactured by: Amneal Pharmaceuticals P…

December 26, 2023 · Drug & medication recalls Moderate risk Failed dissolution specifications

Amneal Pharmaceuticals of New York, LLC recalls Extended Phenytoin Sodium Capsules, USP, 100 mg, 100-count bottle, Distributed by Amneal Pharmaceuticals LLC Bridgewate…

October 27, 2023 · Drug & medication recalls Moderate risk Failed Dissolution Specifications

Amneal Pharmaceuticals of New York, LLC recalls Extended Phenytoin Sodium Capsules, USP, 100 mg, Rx Only, 100 capsules per bottle, Distributed by: Amneal Pharmaceutica…

May 30, 2023 · Drug & medication recalls Moderate risk Failed Dissolution Specifications: Out-of-specification results for dissolution…

Amneal Pharmaceuticals of New York, LLC recalls Methylprednisolone Acetate Injectable Suspension, USP 80 mg/mL, For Intramuscular, Intrasynovial and Soft Tissue Inject…

May 8, 2023 · Drug & medication recalls Labeling: Not Elsewhere Classified; A typographical error was observed in the N…

Amneal Pharmaceuticals of New York, LLC recalls Divalproex Sodium Extended Release Tablets, USP, 250 mg, packaged in 100-count bottle, Rx only, Manufactured by: Amneal…

July 27, 2022 · Drug & medication recalls Moderate risk Failed dissolution specifications.

Amneal Pharmaceuticals of New York, LLC recalls Flocinolone Acetonide 0.01% Topical Oil, Body Oil, Rx, packaged in 4 oz. bottle, Distributed by: Amneal Pharmaceuticals…

November 4, 2021 · Drug & medication recalls Moderate risk Subpotent Drug: Out-of-specification assay result was obtained for Fluocinolone…

Amneal Pharmaceuticals of New York, LLC recalls Flocinolone Acetonide 0.01% Topical Oil, Scalp Oil, Rx, packaged in 4 oz. bottle, Distributed by: Amneal Pharmaceutical…

November 4, 2021 · Drug & medication recalls Moderate risk Subpotent Drug: Out-of-specification assay result was obtained for Fluocinolone…

Amneal Metformin Hydrochloride Extended-Release Tablets recalled over manufacturing violations

May 29, 2020 · Drug & medication recalls Moderate risk CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity a…

Amneal Metformin Hydrochloride Extended-Release Tablets recalled over manufacturing violations

May 29, 2020 · Drug & medication recalls Moderate risk CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity a…

Amneal Metformin Hydrochloride Extended-Release Tablets recalled over manufacturing violations

May 29, 2020 · Drug & medication recalls Moderate risk CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity a…

Amneal Metformin Hydrochloride Extended-Release Tablets recalled over manufacturing violations

May 29, 2020 · Drug & medication recalls Moderate risk CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity a…

Amneal Metformin Hydrochloride Extended-Release Tablets recalled over manufacturing violations

May 29, 2020 · Drug & medication recalls Moderate risk CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity a…

Amneal Metformin Hydrochloride Extended-Release Tablets recalled over manufacturing violations

May 29, 2020 · Drug & medication recalls Moderate risk CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity a…

Amneal Metformin Hydrochloride Extended-Release Tablets recalled over manufacturing violations

May 29, 2020 · Drug & medication recalls Moderate risk CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity a…

Amneal Metformin Hydrochloride Extended-release Tablets recalled over manufacturing violations

May 29, 2020 · Drug & medication recalls Moderate risk CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity a…

Amneal Metformin Hydrochloride Extended-Release Tablets recalled over manufacturing violations

May 29, 2020 · Drug & medication recalls Moderate risk CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity a…

Amneal Metformin Hydrochloride Extended-release Tablets recalled over manufacturing violations

May 29, 2020 · Drug & medication recalls Moderate risk CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity a…

Amneal Metformin Hydrochloride Extended-Release Tablets recalled over manufacturing violations

May 29, 2020 · Drug & medication recalls Moderate risk CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity a…

Amneal Metformin Hydrochloride Extended-release Tablets recalled over manufacturing violations

May 29, 2020 · Drug & medication recalls Moderate risk CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity a…

Nizatidine Oral Solution recalled over manufacturing violations

April 15, 2020 · Drug & medication recalls Moderate risk CGMP Deviations: potential N-Nitrosodimethylamine (NDMA) amounts above levels e…

Amneal Pharmaceuticals of New York, LLC recalls Lorazepam Oral Concentrate, USP, 2 mg/mL, 30 mL bottle, Rx only, Manufactured by: Amneal Pharmaceuticals Branchburg, NJ…

August 3, 2017 · Drug & medication recalls High risk Defective Delivery System: the dropper measurement markings may be reversed, sh…